EP 3644953 A1 20200506 - USE OF N-(4-AMINO-2-METHYLQUINOLINE-6-YL)-2-((4-ETHYLPHENOXY)METHYL)BENZAMIDE FOR PRODUCING COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF SYMPTOMS OF INTRINSIC AND/OR EXTRINSIC SKIN AGING AND FOR THE TREATMENT AND/OR PROPHYLAXIS OF DAMAGING EFFECTS OF ULTRAVIOLET RADIATION ON THE SKIN
Title (en)
USE OF N-(4-AMINO-2-METHYLQUINOLINE-6-YL)-2-((4-ETHYLPHENOXY)METHYL)BENZAMIDE FOR PRODUCING COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF SYMPTOMS OF INTRINSIC AND/OR EXTRINSIC SKIN AGING AND FOR THE TREATMENT AND/OR PROPHYLAXIS OF DAMAGING EFFECTS OF ULTRAVIOLET RADIATION ON THE SKIN
Title (de)
VERWENDUNG VON N-(4-AMINO-2-METHYLCHINOLIN-6-YL)-2-((4-ETHYLPHENOXY)METHYL)BENZAMID ZUR HERSTELLUNG VON KOSMETISCHEN ODER DERMATOLOGISCHEN ZUBEREITUNGEN ZUR BEHANDLUNG UND/ODER PROPHYLAXE DER SYMPTOME DER INTRINSISCHEN UND/ODER EXTRINSISCHEN HAUTALTERUNG SOWIE ZUR BEHANDLUNG UND PROPHYLAXE DER SCHÄDLICHEN AUSWIRKUNGEN ULTRAVIOLETTER STRAHLUNG AUF DIE HAUT
Title (fr)
UTILISATION DE N-(4-AMINO-2-MÉTHYLCHINOLIN-6-YL)-2-((4-ÉTHYLPHÉNOXY)MÉTHYL)BENZAMIDE POUR PRODUIRE DES PRÉPARATIONS COSMÉTIQUES OU DERMATOLOGIQUES DESTINÉES AU TRAITEMENT THÉRAPEUTIQUE ET/OU PROPHYLACTIQUE DES SYMPTÔMES DU VIEILLISSEMENT CUTANÉ INTRINSÈQUE ET/OU EXTRINSÈQUE, AINSI QUE POUR LE TRAITEMENT THÉRAPEUTIQUE ET PROPHYLACTIQUE DES EFFETS NOCIFS DES RAYONS ULTRAVIOLETS SUR LA PEAU
Publication
Application
Priority
- DE 102017212649 A 20170724
- EP 2018063802 W 20180525
Abstract (en)
[origin: WO2019020248A1] The invention relates to the use of N-(4-amino-2-methylquinoline-6-yl)-2-((4-ethylphenoxy)methyl)benzamide for producing cosmetic or dermatological preparations for the treatment and/or prophylaxis of symptoms of intrinsic and/or extrinsic skin aging and for the treatment and/or prophylaxis of damaging effects of ultraviolet radiation on the skin.
IPC 8 full level
A61K 8/49 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP US)
A61K 8/044 (2013.01 - US); A61K 8/062 (2013.01 - US); A61K 8/064 (2013.01 - US); A61K 8/35 (2013.01 - US); A61K 8/37 (2013.01 - US); A61K 8/411 (2013.01 - US); A61K 8/466 (2013.01 - US); A61K 8/4926 (2013.01 - EP US); A61K 8/4946 (2013.01 - US); A61K 8/4966 (2013.01 - US); A61Q 17/04 (2013.01 - US); A61Q 19/08 (2013.01 - EP US); A61K 2800/522 (2013.01 - EP)
Citation (search report)
See references of WO 2019020248A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DE 102017212649 A1 20190124; EP 3644953 A1 20200506; US 2021145723 A1 20210520; WO 2019020248 A1 20190131
DOCDB simple family (application)
DE 102017212649 A 20170724; EP 18730659 A 20180525; EP 2018063802 W 20180525; US 201816633182 A 20180525